Cargando…
CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
INTRODUCTION: The ability to ameliorate murine lupus renders regulatory T cells (Treg) a promising tool for the treatment of systemic lupus erythematosus (SLE). In consideration to the clinical translation of a Treg-based immunotherapy of SLE, we explored the potential of CD4+Foxp3+ Treg to maintain...
Autores principales: | Weigert, Olivia, von Spee, Caroline, Undeutsch, Reinmar, Kloke, Lutz, Humrich, Jens Y, Riemekasten, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672693/ https://www.ncbi.nlm.nih.gov/pubmed/23446139 http://dx.doi.org/10.1186/ar4188 |
Ejemplares similares
-
LMW Heparin Prevents Increased Kidney Expression of Proinflammatory Mediators in (NZBxNZW)F1 Mice
por: Hedberg, Annica, et al.
Publicado: (2013) -
Anti-dsDNA Antibodies Promote Initiation, and Acquired Loss of Renal Dnase1 Promotes Progression of Lupus Nephritis in Autoimmune (NZBxNZW)F1 Mice
por: Fenton, Kristin, et al.
Publicado: (2009) -
Regulatory T cells inhibit autoantigen-specific CD4(+) T cell responses in lupus-prone NZB/W F1 mice
por: Rosenberger, Stefan, et al.
Publicado: (2023) -
Type 1 regulatory T cells in treatment of murine lupus
por: Undeutsch, R, et al.
Publicado: (2005) -
IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis
por: Rose, Angelika, et al.
Publicado: (2019)